National Health Investors INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
National Health Investors Inc. has released its supplemental financial information for the second quarter of 2026, detailing portfolio performance and financial metrics.
NYSE
National Health Investors Inc. announced robust second quarter 2026 results, highlighted by significant growth in its Senior Housing Operating Portfolio (SHOP) and a substantial increase in net income, leading to a dividend hike.
NYSE
National Health Investors, Inc. has appointed Christian Maingot as Chief Operating Officer, effective July 27, 2026, to enhance long-term growth and operational capabilities.
NYSE
National Health Investors, Inc. has completed the sale of 35 healthcare facilities to NHC/OP, L.P., a subsidiary of National HealthCare Corporation, for $560 million.
NYSE
National Health Investors, Inc. has entered into a Change in Control Severance Agreement with executive Todd Siefert, effective July 1, 2026, outlining benefits in the event of termination following a change in control.
NYSE
National Health Investors announces early termination of HSR waiting period for a significant property sale, with closing anticipated around July 1, 2026.
NYSE
National Health Investors, Inc. successfully concluded its 2026 Annual Meeting with shareholders electing all director nominees and ratifying its independent auditor.
NYSE
National Health Investors, Inc. (NHI) provided an investor update on May 4, 2026, including a press release and investor presentation detailing business performance and outlook.
NYSE
National Health Investors Inc. has released its Q1 2026 supplemental information, detailing its real estate investments and senior housing operating portfolio.
NYSE
National Health Investors Inc. reported strong first quarter 2026 results, with key financial metrics exceeding internal expectations, driven by strategic acquisitions and portfolio growth.
NYSE
National Health Investors, Inc. has announced the retirement of CFO John L. Spaid and the appointment of Todd Siefert as his successor.
NYSE
National Health Investors, Inc. announced the sale of its 35-property NHC portfolio for $560 million, aiming to increase private-pay senior housing concentration and strengthen its balance sheet.
NYSE
National Health Investors, Inc. has entered into a definitive agreement to sell 35 senior housing and skilled nursing facilities to National HealthCare Corporation for $560 million.
NYSE
National Health Investors, Inc. has established an Equity Distribution Agreement to sell up to $500 million in common stock for general corporate purposes, including acquisitions and debt repayment.
NYSE
National Health Investors, Inc. announced robust fourth-quarter 2025 results and provided optimistic 2026 guidance, driven by significant SHOP segment growth and strategic investments.
NYSE
National Health Investors reports a stable Q4 2025 with robust portfolio performance and a strong financial position, highlighted by healthy coverage ratios and ample liquidity.
NYSE
National Health Investors reports strong Q4 and full-year 2025 results, surpassing FFO guidance and significantly expanding its Senior Housing Operating Portfolio.
NYSE
National Health Investors, Inc. announced the appointment of Lilly H. Donohue to its Board of Directors and the re-appointment of CEO D. Eric Mendelsohn, completing board declassification.
NYSE
National Health Investors, Inc. updated change in control severance agreements for five key executives, enhancing protections in potential acquisition scenarios.
NYSE
National Health Investors, Inc. announced that board members Robert G. Adams and Charlotte A. Swafford will not seek re-election or will retire, respectively, with no disagreements cited.
NYSE
National Health Investors, Inc. announced robust third-quarter 2025 results, driven by significant SHOP growth and strategic investments, leading to an upward revision of its full-year guidance.
NYSE
National Health Investors furnished Q3 2025 supplemental data highlighting $298.5m annualized adjusted NOI, 1.54x lease coverage, and post-quarter balance sheet moves including a term loan extension and $50m notes repayment.
NYSE
National Health Investors, Inc. announced robust third-quarter 2025 results, driven by strategic SHOP portfolio growth and significant acquisitions, leading to an increased full-year guidance.
NYSE
National Health Investors, Inc. successfully completed an underwritten public offering of $350 million in 5.350% Senior Notes due 2033.
NYSE
National Health Investors, Inc. has issued a formal default notice to NHC/OP, L.P. for non-compliance with its Master Lease covering 35 healthcare facilities.
NYSE
National Health Investors Inc. released its Q2 2025 supplemental information, detailing stable financial performance and improving senior housing operating metrics.
NYSE
National Health Investors, Inc. (NHI) delivered a robust second quarter 2025, driven by significant operational improvements in its senior housing portfolio and a strong financial position.
NYSE
National Health Investors reports strong second quarter results, exceeding expectations and raising full-year Normalized FFO and FAD guidance while increasing its quarterly dividend.
NYSE
National Health Investors, Inc. announced an update to its investment pipeline, now totaling approximately $331.4 million, with significant new commitments in senior housing operating partnerships.
NYSE
National Health Investors, Inc. announced the results of its 2025 Annual Meeting of Stockholders, where key proposals including the declassification of the Board of Directors and the election of four company nominees were approved.